Government
and Business Papers
Welcome
to our section covering Government and Business Papers.
We are going to start with British documents that
refer to Glaxo and Myodil.
I
have chosen not to publish the entire Government File
on Myodil, yet, as reading all of it is unnecessary.
What I have done is to publish extracts from letters
and other papers, together with my own notes on them
in order to make it easier to follow the history of
this toxic pollutant.
If
anybody wants copies of the originals then I will
provide them free of charge, just include a stamped
addressed envelope please. But, if you are prepared
to become an active protestor, there is a better way
in which you can signal the importance to you of this
Myodil/Arachnoiditis issue to the Government.
Simply
send off for a copy of their Myodil file. You are
entitled to it as a UK citizen. Should you meet any
resistance please email me. I will forward a copy
of the emails that produced my copy from an unhappy
Medicines Control Agency forthwith. The Ombudsman
played a large part in assisting me.
As
you progress through these pages you will find my
comments in RED. I have
also emphasised relevant statements in the text by
making them Bold.
There
are references, in the texts to follow, which refer
to other documents that we have yet to publish, this
will be rectified shortly.
Document No. 1
-
Glaxo Fax avoids the Facts
Martin Sutton of Glaxo to David James
Smith of The Sunday Times, 2nd September
1997
|
Document No.1A
-
The Questions Answered(?)
Glaxo's answers to The Sunday Times'
Questions
|
Document No.2
-
GlaxoSmithKline Fax of April 2001
Four years on and the story remains
the same. This document, which also
heralds the merger between SmithKlineBeetcham
and Glaxo, reiterates the 1997 fax.
Nobody has noticed that they have a
problem
|
Document No.3
-
Package Inserts 1971
So having got this far, we now know
that Glaxo, in whichever guise are saying
the same, thing, "We warned everybody
about the dangers of Arachnoiditis on
the 1971 Package Inserts".
Here
we publish the relevant sections of
the Pakage Inserts which form their
defence against culpability. Note the
differences before moving on to our
final document in this series.
|
Document No.4
-
The Doctor tells the tale - 1972
Extracts from the letters of Dr Snell
- Glaxo's Chief Medical Officer in 1972
Replying to various concerned hospital
doctors and the Committee on the Safety
of Medicines, he attempts to explain
away instances of Adverse Drugs Reactions
following Myodil myelograms.
Please note that
he never brings the readers' attentions
to those all important changes on the
1971 Package Inserts.
|
Document No.5
-
Extract from the Adverse Drug Event
Report
Authored again by Dr Snell of Glaxo
this was sent to the CSM listing the
Adverse Drug Events involving Myodil
known to the Company. The reader should
note that there was no appropriate or
reliable ADR reporting system at that
time.
|
|
|
Serious
Questions and doubts regarding Pantopaque
Van Winkle of the FDA to Bucke of Lafayette
21st January 1944 Serious Questions
and doubts regarding Pantopaque prior
to release
|
TOP
|
